Dr. Ben Huang received his undergraduate degree from the University of California (UC) Berkeley in Electrical Engineering and Computer Sciences (EECS) with an honors degree in Molecular and Cell Biology (MCB). He went on to complete his medical, residency/fellowship, and postdoctoral training at UC San Francisco (UCSF) under the mentorship of Dr. Kevin Shannon and with a specific focus on molecular oncology and therapeutics. He is currently a faculty member at UCSF within the Department of Pediatrics, Division of Oncology, and a member of the Helen Diller Family Comprehensive Cancer Center (HDFCCC) and Biomedical Sciences (BMS) Program. The Huang Lab was established in 2022 with a focus on identifying cancer dependencies and harnessing functional and single cell genomics with the long-term goal of developing rationale biologic targeted therapies and more precise assays to detect rare cancer cells and predict cancer recurrence. Our research harnesses accurate and isogenic models of acute myeloid leukemia (AML), CRISPR interference and single cell sequencing technologies, promising clinically relevant small molecule inhibitors, and the largest available pediatric AML sequencing dataset generated to date. In addition, Dr. Huang serves as a contributing member on several national committees, including (but not limited to): the Children's Oncology Group (COG) AML Biology Steering Committee, the COG AAML1831 (NCT04293562) North American Phase 3 Clinical Trial Study Committee, the Leukemia and Lymphoma Society Pediatric Acute Leukemia (LLS PedAL) Target and Biomarker Committee, and the National Cancer Institute Pediatric Cancer Data Commons (NCI PCDC).

Our research is made possible through the support of the NIH/NCI and several additional generous funding sources. We are grateful for and indebted to our past and present research funding sources. We want to extend a special thanks to the patients and families that have devoted their time and efforts to raising funds specifically to support childhood cancer research. Our research is inspired by and committed to improving the outcomes and lives of children diagnosed with cancer and their families.